VC  Vida Ventures

     Office Locations:

40 Broad Street, Suite 201
Boston, MA 02109
Phone: 857-254-9500

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.


  • Early
  • Seed



  • Life Sciences & Healthcare



    Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakthroughs in biomedicine. Its mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida has a bicoastal presence and currently manages approximately $1 billion. Vida Ventures can build and back companies regardless of stage and across therapeutic areas.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Southern California Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Arie Belldegrun M.D. Co-Founder, Sr. Managing Director
    Arjun Goyal M.D., M.Phil, M.B.A. Co-Founder, Managing Director
    David Chang M.D., Ph.D. Scientific Advisor
    Fred Cohen M.D., D.Phil Co-founder & Senior Advisor
    Helen Kim M.B.A. Senior Managing Director


    Recent Funding Events (trailing 12 months):







      Vigil Neuroscience



      Series B


      Volastra Therapeutics





      Aktis Oncology



      Series A


      Centessa Pharmaceuticals



      Series A





      Series B


    Portfolio companies include:

      A2 Biotherapeutics
        web link

      Aktis Oncology
        web link

      Allogene Therapeutics
        web link


      Centessa Pharmaceuticals
        web link

      Dyne Therapeutics
        web link

      Homology Medicines
        web link

      Iconovir Bio


      Kinnate Biopharma
        web link

        web link

      Kronos Bio
        web link

      Kyverna Therapeutics
        web link

        web link

      Neo Gene Therapeutics

      Oyster Point Pharmaceuticals
        web link

      Pact Pharma

      Pionyr Immunotherapeutics
        web link

      Praxis Precision Medicines
        web link

      ReCode Therapeutics
        web link

      Scorpion Therapeutics
        web link

      Vigil Neuroscience
        web link

      Volastra Therapeutics
        web link


    Recent News: